Ignite Creation Date:
2025-12-25 @ 4:32 AM
Ignite Modification Date:
2025-12-26 @ 3:34 AM
Study NCT ID:
NCT05257018
Status:
RECRUITING
Last Update Posted:
2024-11-12
First Post:
2021-12-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse
Sponsor:
Fudan University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Diffuse Large B-cell Lymphoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Chemo-naive Diffuse Large B-cell Lymphoma | View |
| None | Doxorubicin Hydrochloride Liposome Injection | View |
| None | Methotrexate | View |
| None | Central Nervous System Relapsed | View |
| None | R-CDOP | View |
| None | Objective Response Rate | View |
| None | Progression Free Survival | View |
| None | 2-year CNS relapse rate | View |